Oppenheimer Asset Management Inc. Reduces Stock Holdings in Healthpeak Properties, Inc. $DOC

Key Points

• Oppenheimer Asset Management cut its stake in Healthpeak Properties (NYSE:DOC) by 17.4% in Q4, selling 177,357 shares and finishing the quarter with 843,750 shares worth about $13.57 million (0.12% ownership).
• Healthpeak beat Q4 expectations, reporting $0.47 EPS vs. $0.45 consensus and $719.4M revenue vs. $685.1M expected, and set FY2026 guidance of $1.700–$1.740 EPS (analysts’ average ~1.74).
• The company declared a monthly dividend of $0.1017 payable June 26 (record/ex-dividend June 15), implying a 7.4% yield

Oppenheimer Asset Management Inc. lowered its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 17.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 843,750 shares of the real estate investment trust's stock after selling 177,357 shares during the quarter. Oppenheimer Asset Management Inc. owned 0.12% of Healthpeak Properties worth $13,568,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in DOC. JPMorgan Chase & Co. raised its stake in Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the last quarter. Equity Investment Corp raised its stake in Healthpeak Properties by 209.6% in the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust's stock valued at $102,088,000 after purchasing an additional 3,608,849 shares during the last quarter. Bank of America Corp DE raised its stake in Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust's stock valued at $190,292,000 after purchasing an additional 2,206,222 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its stake in Healthpeak Properties by 176.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust's stock valued at $58,663,000 after purchasing an additional 1,955,273 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Up 1.7%

DOC opened at $16.44 on Friday. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. The stock has a market capitalization of $11.43 billion, a price-to-earnings ratio of 164.42, a price-to-earnings-growth ratio of 2.23 and a beta of 1.00. The business has a 50-day moving average of $16.94 and a two-hundred day moving average of $17.17. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $19.68.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating the consensus estimate of $0.45 by $0.02. The company had revenue of $719.40 million during the quarter, compared to analysts' expectations of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm's revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, research analysts expect that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a yield of 7.4%. Healthpeak Properties's payout ratio is 1,220.00%.

Analysts Set New Price Targets

Several research analysts recently weighed in on DOC shares. Evercore cut their target price on shares of Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating for the company in a research note on Wednesday, February 4th. The Goldman Sachs Group started coverage on shares of Healthpeak Properties in a research note on Friday, January 9th. They issued a "neutral" rating and a $17.00 target price for the company. Citigroup cut their target price on shares of Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating for the company in a research note on Wednesday, April 1st. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Saturday. Finally, Robert W. Baird cut their target price on shares of Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating for the company in a research note on Monday, April 6th. Five equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $18.04.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.